Administrative and legislative plans to inhibit or discontinue the purchase of prescription drugs from Canada appears to be a blatant attempt to to protect political fund-raising from the Pharma lobby.
Moreover, said plans dovetail nicely with Obamacare's "death panel" comprised of non-medical, untrained political appointees.